These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12511177)

  • 1. Malignant melanoma: effects of a brief, structured psychiatric intervention on survival and recurrence at 10-year follow-up.
    Fawzy FI; Canada AL; Fawzy NW
    Arch Gen Psychiatry; 2003 Jan; 60(1):100-3. PubMed ID: 12511177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later.
    Fawzy FI; Fawzy NW; Hyun CS; Elashoff R; Guthrie D; Fahey JL; Morton DL
    Arch Gen Psychiatry; 1993 Sep; 50(9):681-9. PubMed ID: 8357293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
    Fairbairn NG; Orfaniotis G; Butterworth M
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
    Crocetti E; Mangone L; Lo Scocco G; Carli P
    Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long-term analysis of 1018 patients with melanoma by classic Cox regression and tree-structured survival analysis at a major referral center: Implications on the future of cancer staging.
    Averbook BJ; Fu P; Rao JS; Mansour EG
    Surgery; 2002 Oct; 132(4):589-602; discussion 602-4. PubMed ID: 12407342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
    Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in young women with cutaneous melanoma.
    Burton AL; Egger ME; Quillo AR; Stromberg AJ; Hagendoorn L; Scoggins CR; Martin RC; McMasters KM; Callender GG
    Am J Surg; 2014 Jan; 207(1):102-8. PubMed ID: 24330977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of the tumor suppressor PLZF is a continuous predictor of long-term survival in malignant melanoma patients.
    Brunner G; Reitz M; Schwipper V; Tilkorn H; Lippold A; Biess B; Suter L; Atzpodien J
    Cancer Biother Radiopharm; 2008 Aug; 23(4):451-9. PubMed ID: 18771349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
    Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
    J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
    Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thin melanomas: predictive lethal characteristics from a 30-year clinical experience.
    Kalady MF; White RR; Johnson JL; Tyler DS; Seigler HF
    Ann Surg; 2003 Oct; 238(4):528-35; discussion 535-7. PubMed ID: 14530724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personality and disease outcome in malignant melanoma.
    Canada AL; Fawzy NW; Fawzy FI
    J Psychosom Res; 2005 Jan; 58(1):19-27. PubMed ID: 15771866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
    Roka F; Kittler H; Cauzig P; Hoeller C; Hinterhuber G; Wolff K; Pehamberger H; Diem E
    Br J Cancer; 2005 Feb; 92(4):662-7. PubMed ID: 15700039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single institute's experience on melanoma prognosis: a long-term follow-up.
    Dika E; Chessa MA; Veronesi G; Ravaioli GM; Fanti PA; Ribero S; Tripepi G; Gurioli C; Traniello Gradassi A; Lambertini M; Patrizi A
    G Ital Dermatol Venereol; 2018 Jun; 153(3):326-332. PubMed ID: 28079338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of patients with melanoma of the lower extremity decreases with distance from the trunk.
    Hsueh EC; Lucci A; Qi K; Morton DL
    Cancer; 1999 Jan; 85(2):383-8. PubMed ID: 10023706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
    Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
    Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
    Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
    JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.